newsfilter
← Latest News
GlobeNewswire·

GBT Announces Proposed Offering of $250.0 Million of Convertible Senior Notes

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it intends to offer $250.0 million aggregate principal amount of its Convertible Senior Notes due 2028 (the "notes")